Containment of tumor-colonizing bacteria by host neutrophils

被引:156
作者
Westphal, Kathrin [1 ]
Leschner, Sara [1 ]
Jablonska, Jadwiga [1 ]
Loessner, Holger [1 ]
Weiss, Siegfried [1 ]
机构
[1] Helmholtz Ctr Infect Res, D-38124 Braunschweig, Germany
关键词
D O I
10.1158/0008-5472.CAN-07-2984
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Administration of facultative anaerobic bacteria like Salmonella typhimurium, Shigella flexneri, and Escherichia coli to tumor-bearing mice leads to a preferential accumulation and proliferation of the microorganisms within the solid tumor. Until now, all known tumor-targeting bacteria have shown poor dissemination inside the tumors. They accumulate almost exclusively in large necrotic areas and spare a rim of viable tumor cells. Interestingly, the bacteria-containing necrotic region is separated from viable tumor cells by a barrier of host neutrophils that have immigrated into the tumor. We here report that depletion of host neutrophils results in a noticeably higher total number of bacteria in the tumor and that bacteria were now also able to migrate into vital tumor tissue. Most remarkably, an increase in the size of the necrosis was observed, and complete eradication of established tumors could be observed under these conditions. Thus, bacteria-mediated tumor therapy can be amplified by depletion of host neutrophils.
引用
收藏
页码:2952 / 2960
页数:9
相关论文
共 23 条
[1]   Bacteriolytic therapy can generate a potent immune response against experimental tumors [J].
Agrawal, N ;
Bettegowda, C ;
Cheong, I ;
Geschwind, JF ;
Drake, CG ;
Hipkiss, EL ;
Tatsumi, M ;
Dang, LH ;
Diaz, LA ;
Pomper, M ;
Abusedera, M ;
Wahl, RL ;
Kinzler, KW ;
Zhou, SB ;
Huso, DL ;
Vogelstein, B .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (42) :15172-15177
[2]  
Bermudes D, 2002, CURR OPIN DRUG DISC, V5, P194
[3]   Overcoming the hypoxic barrier to radiation therapy with anaerobic bacteria [J].
Bettegowda, C ;
Dang, LH ;
Abrams, R ;
Huson, DL ;
Dillehay, L ;
Cheong, I ;
Agrawal, N ;
Borzillary, S ;
McCaffery, JM ;
Watson, EL ;
Lin, KS ;
Bunz, F ;
Baidoo, K ;
Pomper, MG ;
Kinzler, KW ;
Vogelstein, B ;
Zhou, SB .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (25) :15083-15088
[4]  
COLEY WB, 1991, CLIN ORTHOP RELAT R, P3
[5]   Combination bacteriolytic therapy for the treatment of experimental tumors [J].
Dang, LH ;
Bettegowda, C ;
Huso, DL ;
Kinzler, KW ;
Vogelstein, B .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (26) :15155-15160
[6]  
Forbes NS, 2003, CANCER RES, V63, P5188
[7]   Genetically engineered bifidobacterium as a drug delivery system for systemic therapy of metastatic breast cancer patients. [J].
Fujimori M. .
Breast Cancer, 2006, 13 (1) :27-31
[8]   AROMATIC-DEPENDENT SALMONELLA-TYPHIMURIUM ARE NON-VIRULENT AND EFFECTIVE AS LIVE VACCINES [J].
HOISETH, SK ;
STOCKER, BAD .
NATURE, 1981, 291 (5812) :238-239
[9]   Commentary - Can engineered bacteria help control cancer? [J].
Jain, RK ;
Forbes, NS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (26) :14748-14750
[10]  
Lardner A, 2001, J LEUKOCYTE BIOL, V69, P522